AstraZeneca: UK clot review confirms safety of vaccine

“Given the extremely rare rate of occurrence of these events, the benefits of the AstraZeneca vaccine, with the latest data suggesting an 80% reduction in hospitalisation and death from Covid disease, far outweigh any possible risks of the vaccine in the risk groups currently targeted in the UK,” he said.

Source link

Leave a reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.